ICAD INC. - COMMON STOCK

iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)

29 Apr 2025 08:00:01 By Nasdaq GlobeNewswire

iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer

08 Apr 2025 10:19:01 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024

19 Mar 2025 16:01:00 By Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025

11 Mar 2025 08:00:01 By Nasdaq GlobeNewswire

iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America

05 Mar 2025 14:04:32 By Nasdaq GlobeNewswire

Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025

26 Feb 2025 14:46:45 By Nasdaq GlobeNewswire

iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025

19 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ICAD INC. - COMMON STOCK

30 Jan 2025 09:45:10 By NetDania Notify

NetDania - New 12 months High: ICAD INC. - COMMON STOCK

29 Jan 2025 09:57:42 By NetDania Notify

NetDania - New 12 months High: ICAD INC. - COMMON STOCK

28 Jan 2025 09:47:32 By NetDania Notify

NetDania - New 12 months High: ICAD INC. - COMMON STOCK

27 Jan 2025 09:58:08 By NetDania Notify

iCAD Pre-Announces Estimated Q4 2024 Revenue

27 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

11 Dec 2024 10:00:00 By Nasdaq GlobeNewswire

CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024

04 Dec 2024 17:00:00 By Nasdaq GlobeNewswire

iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

26 Nov 2024 13:00:38 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

13 Nov 2024 16:01:00 By Nasdaq GlobeNewswire

iCAD's ProFound Detection Version 4.0 Gains FDA Clearance

12 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

06 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024

05 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024

03 Oct 2024 08:00:00 By Nasdaq GlobeNewswire